Dr. Goy on Promising Data With Acalabrutinib in MCL

preview_player
Показать описание
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses promising data with acalabrutinib in the treatment of patients with mantle cell lymphoma.
Рекомендации по теме